A quality and cost-benefit analysis of dialyzer reuse in hemodialysis patients

Renal Failure

Volumn 30, Issue 5, 2008, Pages 521-526

  Chuang, Feng Rong ^a   Lee, Chih Hsiung ^a   Chang, Hsueh Wen ^b   Lee, Ching Nun ^b   Chen, Te Chuan ^a   Chuang, Chung Hua ^a   Chiou, Terry Ting Yu ^a   Wu, Chien Hsing ^a   Yang, Chih Chao ^a   Wang, I Kuan ^c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cost; Dialyzer reuse; Hemodialysis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; COMORBIDITY; COST; COST BENEFIT ANALYSIS; FEMALE; HEMODIALYSIS; HOLLOW FIBER MEMBRANE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECYCLING; SAFETY; STATISTICAL ANALYSIS; SURVIVAL; TAIWAN;

COST-BENEFIT ANALYSIS; EQUIPMENT REUSE; HUMANS; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS; TAIWAN;

EID: 45749102088     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802064747     Document Type: Article

References (25)

1. Kant KS, Pollak VE, Cathey M, Goetz D, Berlin R. Multiple use of dialyzer: Safety and efficacy. Kidney Int. 1981;19:728-738.
2. Lin CC, Yang MC. Cholesterol oxidation using hollow fiber dialyzer immobilized with cholesterol oxidase: Effect of storage and reuse. Biomaterials. 2003;24:549-557.
3. Feldman HI, Kinosian M, Bilker WB et al. Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA. 1996;276:620-625.
4. Held PJ, Wolfe RA, Gaylin DS, Port FK, Levin NW, Turenne MN. Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis. 1994;23:692-708.
5. Fan Q, Liu J, Ebben JP Collins AJ. Reuse-associated mortality in incident hemodialysis patients in the United States, 2000-2001. Am J Kidney Dis. 2005;46:661-668.
6. Collins AJ, Liu J, Ebben J. Dialyzer reuse-associated mortality and hospitalization risk in incident Medicare haemodialysis patients, 1998-1999. Nephrol Dial Transplant. 2004;19:1245-1251.
7. Hakim RM, Lowrie EG. Effect of dialyzer reuse on leucopenia, hypoxemia and total complement system. ASAIO Trans. 1980;26:159-164.
8. Daugirdas JT, Ing TS. First-use reactions during hemodialysis: A definition of subtype. Kidney Int. 1988;24 (Suppl.):S37-S43.
9. Arduino MJ. How should dialyzers be processed? Semin Dial. 1998;11:282-284.
10. Maidment HJ, Petersen J. The dialysis prescription: Reuse. Am J Nephrol. 1996;16:52-59.
11. Kaehny WD, Miller GE, White WL. Relationship between dialyzer reuse and the presence of anti-N-like antibodies in chronic hemodialysis patients. Kidney Int. 1977;12:59-65.
12. Bland L, Alter M, Favero M, Carson L, Cusick L. Hemodialyzer reuse: Practices in the United States and implication for infection control. Trans Am Soc Artif Intern Organs. 1985;31:556-559.
13. Feldman HI, Bilker WB, Hackett MH, et al. Association of dialyzer reuse with hospitalization and survival rates among U.S. hemodialysis patients: Do comorbidities matter? J Clin Epidemiol. 1999;52:209-217.
14. Hakim RM, Held PJ, Stannard DC et al. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int. 1996;50:566-570.
15. Manns BJ, Taub K, Richardson RMA, Donaldson C. To reuse or not to reuse? An economic evaluation of hemodialyzer reuse verus conventional single-use hemodialysis for chronic hemodialysis patients. International Journal of Technology Assessment in Health Care. 2002;18:81-93.
16. Task Force on Reuse of Dialyzers, Council on Dialysis; National Kidney Foundation. National Kidney Foundation Report on Dialyzer Reuse. Am J Kidney Dis. 1997;30:859-871.
17. Gordon SM, Tipple M, Bland LA, Jarvis WR. Pyrogenic reactions associated with the reuse of disposable hollow-fiber hemodialyzers. JAMA. 1988;260:2077-2081.
18. Port FK, Wolfe RA, Hulbert-Shearon TE et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS Dialysis Morbidity and Mortality Study. Am J Kidney Dis. 2001;37:276-286.
19. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of dialysis-associated diseases in the United States, 1990. Trans Am Soc Artif Intern Organs. 1993;39:71-80.
20. Kes P, Reiner Z, Ratkovic-Gusic I. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent. Acta Medica Croatica. 1997;51:87-93.
21. Ebben JP, Dalleska F, Ma JZ, Everson SE, Constantini EG, Collins AJ. Impact of disease severity and hematocrit level on reuse-associated mortality. Am J Kidney Dis. 2000;35:244-249.
22. Lowrie EG, Li Z, Ofsthun N, Lazarus JM. Reprocessing dialyzers for multiple uses: Recent analysis of death risks for patients. Nephrol Dial Transplant. 2004;19:2823-2830.
23. US Renal Data System. USRDS 2002 Annual Data Report. Bethesda, Md.: National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases; 2002.
24. Brown C. Current opinion and controversies of dialyzer reuse. Saudi J Kidney Dis Transplant. 2001;12:352-363.
25. Lameire N. Management of the hemodialysis patient: A European perspective. Blood Purif. 2002;20:93-102.